FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers
April 14, 2026
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
1 min read